Deep Dives
The syndromes, told in full.
Immersive, citation-grounded monographs on the onco-nephrology lesions worth knowing cold — each from the first description through the mechanism, the landmark studies, the current data, and how it's managed today. Every reference is a real, PubMed-verified paper.
Anti-angiogenics & the glomerular endothelium
VEGF-inhibitor thrombotic microangiopathy
Starve a tumor of its blood supply and you also cut the survival signal podocytes whisper to the glomerular endothelium next door — the capillary tuft answers with thrombi, protein spilling into the urine, and a blood pressure that will not come down.
Platinum & the proximal tubule
Cisplatin acute tubular necrosis & hypomagnesemia
The drug that cures testicular cancer poisons its own portal of entry — pumped into the kidney's S3 tubule by OCT2, cisplatin necroses the proximal tubule and, downstream, silences the distal magnesium channel, leaving patients wasting magnesium long after the last dose.
Anti-EGFR antibodies & the distal tubule
EGFR-inhibitor hypomagnesemia
By occupying the EGF receptor that keeps the TRPM6 channel trafficked to the apical membrane of the distal tubule, cetuximab and panitumumab convert the kidney into a magnesium sieve — an on-target, designed-in toxicity that deepens the longer the drug keeps working.
Medical-education content — not medical advice. Teaching cases are illustrative composites.